Beta Drugs Limited — Dividend/Bonus, 05-02-2025: Bonus

Beta Drugs Limited has approved a bonus issue of shares in the ratio of 1:20, meaning shareholders will receive one new bonus share for every 20 existing shares held, subject to shareholder approval. The proposed increase in authorized share capital will raise it to ₹11 Crore from ₹10.5 Crore. Additionally, two new independent directors, Mrs. Monica Jain and Mr. Lalit Kumar Watts, have been appointed to the board. The resignation of Mrs. Seema Chopra as Whole Time Director has been accepted. The timeline for the bonus share issuance will be finalized following the necessary approvals.